Atara Biotherapeutics Stock (NASDAQ: ATRA) stock price, news, charts, stock research, profile.
Open | $0.688 |
Close | - |
Volume / Avg. | 172.922K / 2.678M |
Day Range | 0.666 - 0.720 |
52 Wk Range | 0.199 - 3.060 |
Market Cap | $82.358M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 9.61% |
Days to Cover | 8.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Atara Biotherapeutics (NASDAQ: ATRA) through any online brokerage.
Other companies in Atara Biotherapeutics’s space includes: Curis (NASDAQ:CRIS), CARISMA Therapeutics (NASDAQ:CARM), Connect Biopharma Hldgs (NASDAQ:CNTB), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for Atara Biotherapeutics (NASDAQ: ATRA) was reported by Stifel on Monday, April 1, 2024. The analyst firm set a price target for 2.30 expecting ATRA to rise to within 12 months (a possible 224.86% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $0.708 last updated Today at April 23, 2024 at 11:04 AM EDT.
There are no upcoming dividends for Atara Biotherapeutics.
Atara Biotherapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Atara Biotherapeutics.
Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.